Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice
MOLECULAR AND CELLULAR ENDOCRINOLOGY(2024)
Abstract
Aim: To evaluate the effects of PPAR alpha and PPAR gamma activation (alone or in combination) on the gut -liver axis, emphasizing the integrity of the intestinal barrier and hepatic steatosis in mice fed a high saturated fat diet. Methods: Male C57BL/6J were fed a control diet (C) or a high -fat diet (HF) for ten weeks. Then, a four -week treatment started: HF-alpha (WY14643), HF-gamma (low -dose pioglitazone), and HF-alpha gamma (combination). Results: The HF caused overweight, insulin resistance, impaired gut -liver axis, and marked hepatic steatosis. Treatments reduced body mass, improved glucose homeostasis, and restored the gut microbiota diversity and intestinal barrier gene expression. Treatments also lowered the plasma lipopolysaccharide concentrations and favored beta -oxidation genes, reducing macrophage infiltration and steatosis in the liver. Conclusion: Treatment with PPAR agonists modulated the gut microbiota and rescued the integrity of the intestinal barrier, alleviating hepatic steatosis. These results show that these agonists can contribute to metabolicassociated fatty liver disease treatment.
MoreTranslated text
Key words
Gut microbiota,PPAR,Tight junctions,Low-dose pioglitazone,Metabolic-associated fatty liver disease,Goblet cells
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined